You searched for "OME"

2928 results found

Sylvester O’Halloran Perioperative Symposium 2024

Co-chair Andrew Dias with best poster winner Nyamateja Kaare. Lisa O’Byrne, ST5 Otolaryngology, St Vincent’s University Hospital, Dublin, Ireland. The annual Sylvester O’Halloran Perioperative Symposium, first held in 1992, has evolved to include all surgical specialties as well as many...

4th Annual Inner Ear Disorders Therapeutics Summit

Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

FDA Approved Lenire Expands Number of US Clinics

Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

Murder most foul, strange and unnatural

Hamlet, written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

History of ENT - Murder most foul, strange and unnatural

Hamlet written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

Challenges in paediatric airway management

Paediatric airway emergencies are high-stakes, but training, simulation and updated guidelines help ENT teams manage risks and build confidence. Congratulations to the ENT Masterclass® on its forthcoming 20th birthday. Over the past two decades, Shahed Quraishi has grown it to...

Michelle – Chevalier Jackson’s choking doll: Simulation in paediatric airway management 100 years ago

Simulation has become an indispensable tool in modern paediatric airway management as it offers clinicians the opportunity to practise complex procedures in a safe, controlled environment [1], although challenges will always remain in replicating the true anatomical proportions and tactile...

IFOS activities

International collaboration is more important than ever, and we hear from Prof Milan Profant about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. IFOS has developed a new philosophy regarding how to organise...

Cambodian Otology Fellowship report

Further to a Humanitarian News article published in the November/December 2014 issue of ENT and Audiology News (see article here), this is a report of Charlie Huins’ six-month experience as the first ENT Fellow at the Children’s Surgical Centre (CSC),...